Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000726218 | SCV000342961 | uncertain significance | not provided | 2016-07-26 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000266439 | SCV000597913 | uncertain significance | not specified | 2015-11-19 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000765980 | SCV000897404 | uncertain significance | Cohen syndrome | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000765980 | SCV001043492 | benign | Cohen syndrome | 2024-01-18 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003910016 | SCV004720357 | likely benign | VPS13B-related disorder | 2022-09-08 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Natera, |
RCV000765980 | SCV001454804 | benign | Cohen syndrome | 2020-09-16 | no assertion criteria provided | clinical testing |